Cargando…

Management of patients with non-Hodgkin’s lymphoma: focus on adoptive T-cell therapy

Non-Hodgkin’s lymphoma (NHL) represents a heterogeneous group of malignancies with high diversity in terms of biology, clinical responses, and prognosis. Standard therapy regimens produce a 5-year relative survival rate of only 69%, with the critical need to increase the treatment-success rate of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Perna, Serena Kimi, Huye, Leslie E, Savoldo, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918257/
https://www.ncbi.nlm.nih.gov/pubmed/27471712
http://dx.doi.org/10.2147/ITT.S31389